| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
-linolenic acid in the diet of term infants: effects on visual function and growth1,2,3
1 From the Department of Paediatrics & Child Health, Flinders University of South Australia and Flinders Medical Centre, Bedford Park (Adelaide), Australia, and Wyeth Nutritionals International, Radnor, PA.
Background: There are nutritional recommendations that the ratio of linoleic to 
-linolenic acid (LA:ALA) in formula for term infants be between 5:1 and 15:1. These recommendations were made in the absence of data on functional or clinical outcomes.
Objective: We compared the fatty acid status, visual evoked potential (VEP) acuity, and growth of term infants fed formula containing an LA:ALA of 10:1 or 5:1 with those of a breast-fed reference cohort.
Design: Formula-fed infants were allocated randomly in a double-blind fashion to receive formula with an LA:ALA of either 10:1 (16.9:1.7; n = 36) or 5:1 (16.3:3.3; n = 37) from near birth to 34 wk of age. Increased ALA was attained by replacing soy oil with low–erucic acid canola oil. A parallel group of breast-fed infants was also recruited. Infant growth and fatty acid status were assessed at 6, 16, and 34 wk of age. VEP acuity was assessed at 16 and 34 wk.
Results: Infants fed the 5:1 formula had greater docosahexaenoic acid (DHA) concentrations in plasma and erythrocyte phospholipids than did infants fed the 10:1 formula, but DHA concentrations of infants fed the 5:1 formula remained less than those in breast-fed infants. The VEP acuity of all formula-fed and breast-fed infants was not significantly different at 16 and 34 wk of age. At birth, infants fed the 5:1 formula were heavier, were longer, and had a greater head circumference than infants assigned to the 10:1 formula group; this differential was maintained throughout the trial. The rate of gain in weight, length, and head circumference was not significantly different between the 2 formula-fed groups, although breast-fed infants had lower weight and length gains than did formula-fed infants between 16 and 34 wk of age.
Conclusion: Lowering the LA:ALA in formula from 10:1 to 5:1 by using low–erucic acid canola oil resulted in a modest increase in plasma DHA but had no effect on VEP acuity or growth rate.
Key Words: -Linolenic acid • ALA • linoleic acid • LA • docosahexaenoic acid • DHA • growth • visual evoked potential • VEP • infants • breast milk • infant formula
Related articles in AJCN:
This article has been cited by other articles:
|
|
 |
|
  G. Barcelo-Coblijn, E. J Murphy, R. Othman, M. H Moghadasian, T. Kashour, and J. K Friel Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid Am. J. Clinical Nutrition, September 1, 2008; 88(3): 801 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R Rudnicka, C. G Owen, M. Richards, M. E. Wadsworth, and D. P Strachan Effect of breastfeeding and sociodemographic factors on visual outcome in childhood and adolescence Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1392 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Huang, J. T. Brenna, A. C. Chao, C. Tschanz, D. A. Diersen-Schade, and H.-C. Hung Differential Tissue Dose Responses of (n-3) and (n-6) PUFA in Neonatal Piglets Fed Docosahexaenoate and Arachidonoate J. Nutr., September 1, 2007; 137(9): 2049 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Singhal, R. Morley, T. J Cole, K. Kennedy, P. Sonksen, E. Isaacs, M. Fewtrell, A. Elias-Jones, T. Stephenson, and A. Lucas Infant nutrition and stereoacuity at age 4-6 y Am. J. Clinical Nutrition, January 1, 2007; 85(1): 152 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L Cheatham, J. Colombo, and S. E Carlson n-3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1458 - 1466S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Heinemann, M. K. Waldron, K. E. Bigley, G. E. Lees, and J. E. Bauer Long-Chain (n-3) Polyunsaturated Fatty Acids Are More Efficient than {alpha}-Linolenic Acid in Improving Electroretinogram Responses of Puppies Exposed during Gestation, Lactation, and Weaning J. Nutr., August 1, 2005; 135(8): 1960 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. J. Muskiet, M. R. Fokkema, A. Schaafsma, E. R. Boersma, and M. A. Crawford Is Docosahexaenoic Acid (DHA) Essential? Lessons from DHA Status Regulation, Our Ancient Diet, Epidemiology and Randomized Controlled Trials J. Nutr., January 1, 2004; 134(1): 183 - 186. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blank, M. A. Neumann, M. Makrides, and R. A. Gibson Optimizing DHA levels in piglets by lowering the linoleic acid to {alpha}-linolenic acid ratio J. Lipid Res., September 1, 2002; 43(9): 1537 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Weiler and S. C. Fitzpatrick-Wong Modulation of Essential (n-6):(n-3) Fatty Acid Ratios Alters Fatty Acid Status but Not Bone Mass in Piglets J. Nutr., September 1, 2002; 132(9): 2667 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mendez, M. S. Anthony, and L. Arab Soy-Based Formulae and Infant Growth and Development: A Review J. Nutr., August 1, 2002; 132(8): 2127 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Makrides, J. S Hawkes, M. A Neumann, and R. A Gibson Nutritional effect of including egg yolk in the weaning diet of breast-fed and formula-fed infants: a randomized controlled trial Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1084 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A Tolley and S. E Carlson Considerations of statistical power in infant studies of visual acuity development and docosahexaenoic acid status1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 1 - 2. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
